Skip to content

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

Effect of 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia Among Hospitalized Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04403971
Enrollment
103
Registered
2020-05-27
Start date
2020-05-25
Completion date
2020-12-31
Last updated
2021-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-acquired Pneumonia

Keywords

0.12% chlorhexidine, Oral rinse, Hospital-acquired pneumonia

Brief summary

Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-acquired pneumonia among hospitalized patients.

Detailed description

Participants will be classified into three groups, applied twice a day by care givers. Oral colonization will be tested in the baseline, day-3, day-7, and at the discharge. Quantitation of colonization of the oral cavity by oral rinses and respiratory pathogens were measured.

Interventions

DRUG0.12% Chlorhexidine Oral Liquid Product

The intervention group 1 received 10ml 0.12% chlorhexidine solution for oral rinse twice a day.

DRUGListerine Oral Liquid Product

The intervention group 2 received 10ml Listerine solution for oral rinse twice a day.

OTHERNormal Saline Product

The control group received 10ml normal saline for oral rinse twice a day.

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Hospitalized patients \> 20 years old without ventilator

Exclusion criteria

* known hypersensitivity to or intolerance of Chlorhexidine or Listerine

Design outcomes

Primary

MeasureTime frame
oral bacterial colonization status1 year

Secondary

MeasureTime frame
The rate of non-ventilator associated pneumonia1 year

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026